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Abstract
To identify previously reported disease mutations that are compatible with
extraordinary longevity, we screened the coding regions of the genomes of 44
Ashkenazi Jewish centenarians. Individual genome sequences were generated
with 309 coverage on the Illumina HiSeq 2000 and single-nucleotide variants
were called with the genome analysis toolkit (GATK). We identified 130 coding
variants that were annotated as “pathogenic” or “likely pathogenic” based on
the ClinVar database and that are infrequent in the general population. These
variants were previously reported to cause a wide range of degenerative, neoplastic, and cardiac diseases with autosomal dominant, autosomal recessive, and
X-linked inheritance. Several of these variants are located in genes that harbor
actionable incidental findings, according to the recommendations of the American College of Medical Genetics. In addition, we found risk variants for lateonset neurodegenerative diseases, such as the APOE e4 allele that was even
present in a homozygous state in one centenarian who did not develop Alzheimer’s disease. Our data demonstrate that the incidental finding of certain
reported disease variants in an individual genome may not preclude an extraordinarily long life. When the observed variants are encountered in the context of
clinical sequencing, it is thus important to exercise caution in justifying clinical
decisions.
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Introduction
Human genetic studies have linked many variants to
human diseases or nondisease phenotypes. How to handle
the incidental finding of a disease variant is a topic of
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current discussion (Green et al. 2013a; Klitzman et al.
2013). Incidental findings often occur, when genome
sequencing data are screened for disease-causing variants
that are recorded in databases such as Online Mendelian
Inheritance in Man (OMIM) (Hamosh et al. 2005) or,
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more recently, ClinVar (Landrum et al. 2014) and the
Genome Wide Association Studies (GWAS) catalog
(Hindorff et al. 2009). However, the penetrance of these
recorded variants spans a broad spectrum, ranging from
complete penetrance for a set of monogenic mutations to
the very small effect sizes of many GWAS hits. While it is
widely known that most GWAS hits have only limited clinical prognostic relevance, the penetrance and prognostic
value of many previously reported monogenic mutations is
less clear. Recently, a significant percentage of such putative “disease mutations” were claimed to be of questionable
pathogenicity (Cassa et al. 2013; Dorschner et al. 2013;
Flannick et al. 2013; Kenna et al. 2013; Riggs et al. 2013).
Accordingly, it is an important aim of current human
genetic research to systematically assess the clinical significance of genetic variants (Duzkale et al. 2013). As one way
to identify those mutations that may require reinterpretation, we use a sample of individuals with exceptional longevity to identify reported disease mutations for which the
pathogenicity status should be preferentially reevaluated.
If a mutation for a dominant late-onset disease is
encountered in the genome of a younger individual, a
reduced penetrance is difficult to assign without longitudinal follow-up. In addition to the uncertain significance
of many reported mutations for dominant diseases, the
traditional assumption that heterozygous carriers for
recessive disease alleles are unaffected (Nussbaum et al.
2007) may not hold true. For instance, Gaucher’s disease
alleles in the GBA gene have been found to strongly
increase the risk of developing Parkinson’s disease
(Sidransky et al. 2009) as well as dementia with Lewy
bodies (Nalls et al. 2013). Similarly, heterozygous carriers
for autosomal recessive disease alleles for Alport
syndromes have increased risk of renal failure (Temme
et al. 2012). Therefore, different lines of evidence need to
be integrated to assign a clinical significance score to each
variant. For mutations previously linked to dominant
diseases that negatively affect life expectancy, their observation in centenarian genomes may be viewed as evidence
for unclear pathogenicity or at least incomplete penetrance. To a certain extent, reduced penetrance could
result from a variety of protective genetic, epigenetic,
environmental, and random factors (Cooper et al. 2013)
or other buffering mechanisms (Bergman et al. 2007).
In the present study, we search the coding regions of
44 Ashkenazi Jewish (AJ) centenarians for variants that
were previously reported as causal mutations for medically relevant phenotypes. To this end, we use the recently
established and publicly accessible ClinVar database (Riggs et al. 2013) which not only provides highly structured
data access but also includes community-based data curation (Landrum et al. 2014). We chose ClinVar because of
the quality of its content. Our study is meant to be part
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of the community effort to further improve its quality,
which is eased by its free availability. Such databases are
gaining in importance, because the increased utilization
of next-generation sequencing technology magnifies the
challenge to interpret genetic testing results (Lyon and
Wang 2012; Lohn et al. 2013; Manolio et al. 2013; Rehm
et al. 2013). For example, in August 2013 the ClinVar
database recorded 14,746 variants classified as pathogenic
and 1672 as probably pathogenic. We focus on the
description of those variants that have been previously
reported as Mendelian disease mutations that would
increase the risk of mortality, such as degenerative diseases, neoplasm, and cardiac diseases. The observation of
previously reported disease variants in centenarian genomes may aid clinical geneticists who are confronted
with the challenge to evaluate their pathogenicity.

Materials and Methods
Study population
DNA samples of 44 AJ centenarians were collected as part
of a longevity study at the Albert Einstein College of Medicine that was described elsewhere (Barzilai et al. 2003).
The sample includes eight male (95–103 years old) and 36
female (95–106 years old) subjects. The mean and median
age of the subjects was 99.6 and 100 years (standard deviation r = 3.1). Informed written consent was obtained in
accordance with the policy of the Committee on Clinical
Investigations of the Albert Einstein College of Medicine.
Genomic DNA extracted from blood cells using standard
procedure was sent for sequencing. Mini-mental status
examinations (MMSE) (Folstein et al. 1975) and selected
health status information such as hearing, vision, and
whether a subject had a history of cancer or myocardial
infarction (MI) are available for the majority of the centenarians. The level of education was not available. Given
that median MMSE scores are found to be a function of
age and level of education (Crum et al. 1993; Bravo and
Hebert 1997) and can be as low as 20 for people 85 years
and older with <4 years of education (Crum et al. 1993),
we use the reference score of ≥24 (one standard deviation
of the mean MMSE score for people 85 and older; Bravo
and Hebert 1997) to exclude the presence of dementia in
our sample. To our knowledge, no reference MMSE scores
specifically for centenarians are available.

Genome sequencing and variant calling
Whole genome sequencing was performed on Illumina
HiSeq 2000 platform (Illumina, San Diego, CA). Pairedend 2 9 100 reads were aligned to the GRCh37 human
reference using the Burrows-Wheeler Aligner (BWA) (Li
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and Durbin 2009) and processed using the best-practices
pipeline that includes marking of duplicate reads by the
use of Picard tools (http://picard.sourceforge.net), and
realignment around DNA insertions and deletions (indels)
and base recalibration via Genome Analysis Toolkit
(GATK) Lite ver. 2.3-9 (McKenna et al. 2010). Singlenucleotide variants (SNVs) were jointly called on the 44
unrelated AJ centenarians together with HapMap trio
NA12877, NA12878, and NA12882 using the UnifiedGenotyper module of GATK Lite. The HapMap trio was
sequenced at Illumina and released as part of the
PlatinumGenomes project (http://www.illumina.com/platinumgenomes). We used variant quality score recalibration
and Mendelian inconsistencies on the HapMap trio to
determine the optimal variant quality score (VQSLOD)
cutoff.
Joint calling for transcribed gene regions of 44 AJ centenarians identified a total of 6.3 million genetic variants. A
total of 87,899 coding SNVs were found (100% call rate)
in coding regions defined by the longest transcript according to the UCSC hg19 database (Meyer et al. 2012). For
variants with a VQSLOD score >2, the concordance rate
for SNVs between Illumina 2.5M chip and GATK variant
calls was above 99.7% for all subjects. Due to the comparatively lower performance of the UnifiedGenotyper in calling short insertions and deletions, in the present study we
decided not to analyze insertion/deletion variants.

Database annotation of variants
Using custom scripts and the SNP & Variation Suite software (Version 7.7.8; Golden Helix, Inc., Bozeman, MT,
www.goldenhelix.com), we annotated coding and splice
variants based on the knownGene and the refGene tracks
in the UCSC hg19 database (Meyer et al. 2012). To find
variants of potential clinical relevance, variants were evaluated for their possible pathogenicity based on the August
2013 version of the ClinVar database (http://www.ncbi.
nlm.nih.gov/clinvar/) (Riggs et al. 2013). This database
provides free highly structured public access to clinically
relevant sequence variants and it also provides evidencebased interpretation of clinical significance for each variant (Landrum et al. 2014). All ClinVar accession numbers
for the identified variants are linked to the respective
NCBI (The National Center for Biotechnology Information) database for reference sequences (RefSeq) as well as
OMIM accession numbers. Population allele frequencies
of variants were retrieved from the NHLBI Exome
Sequencing Project (ESP) database (Exome Variant Server, NHLBI GO ESP, Seattle, WA) (http://evs.gs.washington.edu/EVS). To our knowledge, a similar large-scale
population allele frequency data specific for the AJ population are currently not available.
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Quality control filtering of putative disease
variants
A total of 225 autosomal and seven X-chromosomal coding SNVs were found to be annotated as “pathogenic” or
“likely pathogenic” in the ClinVar database. Eighteen of
these variants had a VQSLOD score <4, most often due to
poor mapping quality indicating genomic segmental duplications. However, genomic regions that are difficult to
map are also known to produce false-negative variant calls
(Lee and Schatz 2012). Therefore, we performed manual
evaluation of the 18 variants. These include two mutations
in the gene GBA that are known to cause Gaucher disease
as well as being associated with late-onset Parkinson’s disease (most frequently referred to in the literature as L444P
[uc001fjh.2:c.T1449C:p.L483P] and N370S [uc001fjh.2:
c.A1227G:p.N409S]). Both mutations are known to be relatively frequent in the AJ population (Scott et al. 2010).
Using BLAT (Kent 2002), N409S (rs76763715) was
uniquely mapped to chromosome 1:155205634 and L483P
(rs421016) was uniquely mapped to chr1:155205043. Thus,
both variants are likely to be true SNVs in our sample and
were therefore retained. The remaining 16 variants with
low VQSLOD scores were removed.

Results
In the coding regions of 44 centenarian genomes, we
found 210 autosomal and six X-chromosomal SNVs that
passed quality control. Among these, 207 variants were
classified as pathogenic and nine as likely pathogenic
based on the ClinVar database. Excluding the two APOE
risk variants, 86 of these SNVs were found to be common
defined as minor allele frequency (MAF) of 5% or higher
in either the European or African American populations
in the ESP database (Table S1). Due to their high allele
frequency in the general population, these 86 variants are
considered unlikely to be strongly pathogenic with high
penetrance and therefore not further discussed. According
to the OMIM database, of the remaining 130 variants
(Tables 1–5 and S2), 39 were reported to cause autosomal
dominant diseases, 72 to cause autosomal recessive diseases, 6 were associated with X-chromosomal inheritance,
and 13 with other modes of inheritance such as digenic,
imprinting, complex, or unclear mode of inheritance.

Variants reported as causal for
degenerative diseases of advanced age
Variants associated with age-related degenerative diseases
were found in the genes APOE, GBA, UBQLN2, SEMA4A,
RP1, MYO1A, CYP1B1, OPTN, VSX1, and WDR36
(Table 1).
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155205634

156146640
38298394
110441839
110454719
55537560
13178766
57431402
57437119
45411941

45412079

25060096
56591879

1

1
2
5
5
8
10
12
12
19

19

20
X

rs74315433
rs369947678

rs7412

rs41265017
rs79204362
rs35703638
rs34595252
rs77775126
rs75654767
rs33962952
rs55679042
rs429358

rs76763715

rs421016

ID

C
c

C

G
C
G
A
C
G
C
C
T

T

A

REF

T
T

T

A
T
A
G
T
A
T
T
C

C

G

ALT

43/1/0
43/1/0

33/11/0

34/10/0
41/3/0
43/1/0
43/1/0
43/1/0
43/1/0
32/10/2
43/1/0
39/4/1

43/1/0

43/1/0

AC

VSX1
UBQLN2

APOE

SEMA4A
CYP1B1
WDR36
WDR36
RP1
OPTN
MY01A
MY01A
APOE

GBA

GBA

Gene

uc002wuf.2:c.G480Ap.G160D
uc004dus.2:c.C1574T:p.P525S

uc002pab.2:c.C527T:p.R176C

uc001fnm.2:c.G2139A:p.R713Q
uc002rqo.2:c.G1104Ap.R368H
uc003kpd.2:c.G1346A:p.A449T
uc003kpd.2:c.A1974G:p.D658G
uc003xsd.1 :c.C1119T:p.T373l
uc001ilx1:c.G1635A:p.R545Q
uc001smw.3:c.G1986Ap.G662E
uc001 smw.3:c.G917A:p.V306M
uc002pab.2:c.T389C:p.C130R

uc001fjh.2:c.A1227G:p.N409S

uc001fjh.2:c.T1449C:p.L483P

Effect
Gaucher’s disease; late-onset Parkinson’s
disease; susceptibility to dementia with
Lewy body
Gaucher’s disease; late-onset Parkinson’s
disease; susceptibility to dementia with
Lewy body
Retinitis pigmentosa 35
Glaucoma early-onset digenic
Glaucoma 1, open angle
Glaucoma 1, open angle
Retinitis pigmentosa 1
Glaucoma 1, open angle
Deafness, autosomal dominant 48
Deafness, autosomal dominant 48
Hyperlipoproteinemia, type 3, autosomal
dominant; Alzheimer’s disease associated
with APOE4 variant
Familial type 3 hyperlipoproteinemia,
associated with APOE2
Keratoconus 1
Amyotrophic lateral sclerosis 15 with or
without frontotemporal dementia

CLNDBN

RCV000024251
RCV000022846

RCV000019428

RCV000003528
RCV000008178
RCV000001649
RCV000001647
RCV000006334
RCV000007515
RCV000008627
RCV000008625
RCV000019438;
RCV000019448

RCV000004515;
RCV000004516

RCV000004511;
RCV000004512

CLNACC

605020
300264

107741

607292
601771
609669
609669
603937
602432
601478
601478
107741

606463

606463

OMIM

CHR, chromosome; POS, position on chromosome based on GRCh37; ID, dbSNP ID; REF, reference sequence; ALT, alternative sequence; AC, counts of subjects with homozygous reference
alleles/heterozygous/homozygous nonreference alleles; Effect, position of nucleotide change on UCSC transcript and amino acid change; CLNDBN and CLNACC, selected disease condition and
accession ID from ClinVar; OMIM, OMIM accession numbers for the genes.

155205043

POS

1

CHR

Table 1. Putative disease variants reported to cause degenerative diseases.
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17354297
182555149
112175240
16012594
43613908
67258382
12899902
41226488
1223125

1
1
5
8
10
11
17
17
19

rs33927012
rs74315364
rs1801166
rs41341748
rs77724903
rs104894190
rs5030739
rs1800744
rs59912467

ID
A
C
G
G
A
G
C
C
C

REF
G
A
C
A
T
A
T
A
G

ALT
43/1/0
43/1/0
43/1/0
43/1/0
42/2/0
41/3/0
38/6/0
42/2/0
43/1/0

AC
SDHB
RNASEL
APC
MSR1
RET
MP
ELAC2
BRCA1
STK11

Gene
uc001 bae.2:c.T488C:p.S163P
uc001gpj.1:c.G794T:p.E265*
uc003kpy.3:c.G3950C:p.E1317Q
uc003wwz.2:c.C878T:p.R293*
uc001jal.2:c.A2373T:p.Y791 F
uc001olv.2:c.G912A:p.R304Q
uc002gnz.3:c.G1622A:p.A541 T
uc002ict.2:c.G4599T:p.S1533I
uc002lrl.1:c.C1063G:p.F355L

Effect
Cowden-like syndrome
Prostate cancer, hereditary
Adenomatous polyposis coli
Malignant tumor of prostate
Familial medullary thyroid carcinoma
Pituitary-dependent hypercortisolism
Prostate cancer, hereditary
Familial cancer of breast
Peutz–Jeghers syndrome

CLNDBN
RCV000013633
RCV000013878
RCV000000872
RCV000015431
RCV000014962
RCV000005171
RCV000005359
RCV000048588
RCV000007887

CLNACC

185470
180435
611731
153622
164761
605555
605367
113705
602216

OMIM

2659186
22017410
111356964

42744802

35742938

12
12
12

20

21

rs74315447

rs140740776

rs121912775
rs61688134
rs104894363

rs193922635
rs113449357
rs45454496

ID

T

C

G
C
C

C
C
G

REF

C

T

A
T
T

T
T
A

ALT

43/1/0

42/2/0

43/1/0
42/2/0
43/1/0

43/1/0
43/1/0
42/2/0

AC

KCNE2

JPH2

CACNA1C
ABCC9
MYL2

ACTN2
TMEM43
ANK2

Gene

uc002ytt.1 :c.T162C:p.M54T

uc002xli.1:c.G1514A:p.G505S

uc001qkl.2:c.G1469A:p.G490R
uc001 rfh.2:c.G2201 A:p.V734l
uc001try.3:c.G38Ap.A13T

uc001hyf.2:c.C2148T:p.T716M
uc003byk.2:c.C935T:p.R312W
uc003ibe.3:c.G11792A:p.E3931K

Effect

Cardiomyopathy
Cardiomyopathy
Cardiac arrhythmia,
ankyrin B-related
Brugada syndrome 3
Myocardial infarction 1
Familial hypertrophic
cardiomyopathy 10
Familial hypertrophic
cardiomyopathy 17
Long QT syndrome 6

CLNDBN

RCV000006425

RCV000023411

RCV000019201
RCV000029274
RCV000015108

RCV000029298
RCV000030555
RCV000019677

CLNACC

603796

605267

114205
601439
160781

102573
612048
106410

OMIM

CHR, chromosome; POS, position on chromosome based on GRCh37; ID, dbSNP ID; REF, reference sequence; ALT, alternative sequence; AC, counts of subjects with homozygous reference
alleles/heterozygous/homozygous nonreference alleles; Effect, position of nucleotide change on UCSC transcript and amino acid change; CLNDBN and CLNACC, selected disease condition and
accession ID from ClinVar; OMIM, OMIM accession numbers for the genes.

236918491
14180731
114294537

POS

1
3
4

CHR

Table 3. Putative disease variants reported to cause autosomal dominant cardiac diseases.

CHR, chromosome; POS, position on chromosome based on GRCh37; ID, dbSNP ID; REF, reference sequence; ALT, alternative sequence; AC, counts of subjects with homozygous reference
alleles/heterozygous/homozygous nonreference alleles; Effect, position of nucleotide change on UCSC transcript and amino acid change; CLNDBN and CLNACC, selected disease condition and
accession ID from ClinVar; OMIM, OMIM accession numbers for the genes.

POS

CHR

Table 2. Putative disease variants reported to cause neoplastic diseases.
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18080001
55372085
106431420
6442643

32351535
54418579
74704267
1129586
72745313

58039060
11240278

8
8
8
12

13
14
15
16
17

18
19

rs121913563
rs137853964

rs121918303
NA
rs56001514
rs121917877
rs35910969

rs4987076
NA
rs121908601
rs4149584

rs61816761
rs41268673
rs121908120
rs28936670
rs104893904
rs121912575
rs55758736

ID

C
G

A
T
G
C
C

G
T
A
C

G
G
T
G
C
C
G

REF

T
A

C
C
A
T
G

A
A
G
T

A
T
A
A
G
T
A

ALT

43/1/0
43/1/0

38/6/0
43/1/0
43/1/0
42/2/0
43/1/0

39/5/0
42/2/0
42/2/0
41/3/0

42/2/0
36/7/1
41/3/0
43/1/0
43/1/0
42/2/0
42/2/0

AC

MC4R
LDLR

RXFP2
BMP4
SEMA7A
SSTR5
SLC9A3R1

NAT1
SOX17
ZFPM2
TNFRSF1A

FLG
SCN9A
WNT10A
NKX2-5
NKX2-5
TNXB
BLK

Gene

uc002lie.1:c.G524A:p.A175T
uc002mqk.3:c.G2480A:p.V827l

uc001 utt.2:c.A665C:p.T222P
uc010aoh.2:c.A363G:p.H121R
uc002axv.2:c.C1382T:p.R461C
uc002ckq.2:c.C719T:p.R240W
uc002jlo.2:c.C329G:p.L110V

uc003wys.2:c.G632A:p.V211l
uc003xsb.3:c.T776Ap.Y259N
uc003ymd.2:c.A90G:p.E30G
uc001qnu.2:c.G363A:p.R121Q

uc001 ezu.1:c.C1502T:p.R501*
uc010fpl.2:c.C1829A:p.P610T
uc002yjd.1:c.T683Ap.F228l
uc003mcm.1:c.C74T:p.R25C
uc003mcm.1:c.G62C:p.E21Q
uc003nzl.2:c.G3323Ap.V1108M
uc003wty.2:c.G212Ap.A71T

Effect
Ichthyosis vulgaris
Primary erythromelalgia
Odontoonychodermal dysplasia
Tetralogy of Fallot
Tetralogy of Fallot
Ehlers–Danlos syndrome type 3
Maturity-onset diabetes of the
young type 11
NAT1*7 ALLELE
Vesicoureteral reflux 3
Tetralogy of Fallot
TNF receptor-associated periodic fever
syndrome (TRAPS)
Cryptorchidism, unilateral or bilateral
Microphthalmia syndromic 6
Blood group John Milton Hagen system
Resistance to somatostatin analog
Nephrolithiasis/osteoporosis,
hypophosphatemic 2
Obesity
Familial hypercholesterolemia

CLNDBN

RCV000015406
RCV000030135

RCV000004376
RCV000022458
RCV000029235
RCV000013734
RCV000005588

RCV000019386
RCV000001140
RCV000006502
RCV000013134

RCV000017712
RCV000020511
RCV000004717
RCV000009572
RCV000009574
RCV000009083
RCV000013112

CLNACC

155541
606945

606655
112262
607961
182455
604990

108345
610928
603693
191190

135940
603415
606268
600584
600584
600985
191305

OMIM

CHR, chromosome; POS, position on chromosome based on GRCh37; ID, dbSNP ID; REF, reference sequence; ALT, alternative sequence; AC, counts of subjects with homozygous reference
alleles/heterozygous/homozygous nonreference alleles; Effect, position of nucleotide change on UCSC transcript and amino acid change; CLNDBN and CLNACC, selected disease condition and
accession ID from ClinVar; OMIM, OMIM accession numbers for the genes.

152285861
167141109
219755011
172662014
172662026
32052313
11405576

POS

1
2
2
5
5
6
8

CHR

Table 4. Putative disease variants reported to cause other autosomal dominant diseases.
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CHR, chromosome based on GRCh37; POS, position on chromosome; ID, dbSNP ID; REF, reference sequence; ALT, alternative sequence; ALT_AC, nonreference allele counts; Effect, position of
nucleotide change on UCSC transcript and amino acid change; CLNDBN and CLNACC, selected disease condition and accession ID from ClinVar; OMIM, OMIM accession numbers for the genes.

300377
300377
300377
300603
314200
RCV000012020
RCV000012019
RCV000012018
RCV000011541
RCV000010442
Becker muscular dystrophy
Duchenne muscular dystrophy
Duchenne muscular dystrophy
Premature ovarian failure 2b
Thyroxine-binding globulin variant p
uc004dda.1:c.A8763G:p.H2921R
uc004dda.1:c.A8735G:p.N2912D
uc004dda.1:c.A8730T:p.E2910V
uc004eer.2:c.G987A:p.R329Q
uc004eme.1:c.G910T:p.L304F
DMD
DMD
DMD
POF1B
SERPINA7
1
1
1
0
1
31496398
31496426
31496431
84563194
105278361
X
X
X
X
X

rs1800279
rs1800278
rs41305353
rs75398746
rs1804495

T
T
T
C
C

C
C
A
T
A

4
1
1
2
11

Gene
ALT_AC
(male)
ALT_AC
ALT
REF
ID
POS
CHR

Table 5. Putative disease mutations reported to cause X-chromosomal diseases.

Effect

CLNDBN

CLNACC

OMIM
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Given the important role of APOE variants in lateonset Alzheimer’s disease, we first looked at the APOE e4
allele as defined by the ancestral alleles rs429358-C and
rs7412-C (130Arg and 176Arg) and APOE e2 allele as
defined by rs429358-T and rs7412-T (130Cys and
176Cys). In our centenarian sample, the allele frequencies
for APOE e4, e3, and e2 were 6.8%, 80.7%, and 12.5%,
respectively. One of the two e2/e4 and one of the two e3/
e4 heterozygous carriers were found to have advanced
dementia of unknown etiology and the other two subjects
were cognitively intact. Notably, the centenarian homozygous for the e4 allele had an MMSE score of 25 at age 97.
Neither this centenarian nor any other subject in our
study carried the protective variant A673T in the APP
gene (Jonsson et al. 2012). We also observed one carrier
for each of the known GBA mutations L483P (also known
as L444P) (rs421016) and N409S (N370S) (rs76763715),
which is in line with the reported frequency of 3% for
either mutation in AJ controls (Sidransky et al. 2009).
On the X chromosome we identified a female centenarian with a previously described mutation in UBQLN2
P525S (Deng et al. 2011), which was found to cause an
X-linked dominant type of familial amyotrophic lateral
sclerosis (ALS) and ALS/dementia with an estimated penetrance of approximately 90% (Table 1). This subject had
normal MMSE (score = 28) at age 102 without any neurological symptoms.
Furthermore, disease alleles were observed for other
autosomal dominantly inherited degenerative diseases of
sensory function, including retinitis pigmentosa
(SEMA4A, RP1), deafness (MYO1A), glaucoma (CYP1B1,
OPTN, WDR36), and keratoconus (VSX1). Of note, none
of the 10 centenarians carrying the SEMA4A R713Q had
vision impairment but the single subject carrying the RP1
T373I was blind. No hearing impairment was noticed in
one of two subjects homozygous and four of ten heterozygous carriers of the MYO1A G662E variant that was
linked to an autosomal dominant form of deafness.

Variants for neoplastic diseases
We found variants in the five genes APC, BRCA1, RET,
RNASEL, and STK11 that were linked to autosomal dominant forms of cancer or neoplasm as well as four complex risk variants in ELAC2, MSR1, AIP, and SDHB
(Table 2). The clinical relevance of these variants has been
discussed in the literature and their presence in the genomes of centenarians indicates that these variants are
compatible with exceptional longevity.
The tumor suppressor gene STK11 variant F355L
(rs59912467) linked to Peutz–Jeghers syndrome was seen
in one centenarian. It was reported to affect both the
AMPK pathway and cell polarity, thus contributing to the
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development of malignancies (Forcet et al. 2005). Notably, the same subject carried two additional variants
linked to thyroid carcinoma (RET Y791F, rs77724903)
and Cowden-like syndrome (SDHB S163P, rs33927012),
but was free of any type of neoplasia at age 97. The
Y791F variant in the RET protooncogene was further
present in another centenarian with a history of cancer of
unknown origin. This variant was first described in two
German families with familial medullary thyroid carcinoma (Berndt et al. 1998). Six centenarians carried the
A541T variant in the gene ELAC2 (rs5030739) that was
reported to be associated with prostate cancer (Rebbeck
et al. 2000; Tavtigian et al. 2001; Camp and Tavtigian
2002). One of the two male carriers for A541T had no
cancer at age 103 years and the other had an unknown
type of cancer.

Variants for autosomal dominant forms of
cardiac disease
We found variants in ABCC9, ACTN2, ANK2, CACNA1C,
JPH2, KCNE2, MYL2, and TMEM43 that were linked to
autosomal dominant phenotypes affecting cardiac function (Table 3).
Three of the variants in these genes are annotated as
causes of cardiac arrhythmia with increased risk of sudden cardiac death. Two centenarians were heterozygous
for the E3931K variant in ANK2 (rs45454496) variant,
also known as E1813K, which was reported as a loss-offunction mutation in the ankyrin-B regulatory domain
(Mohler et al. 2003, 2004). One centenarian carried the
G490R variant in CACNA1C (rs121912775), a loss-offunction change that was linked to Brugada syndrome 3
(Antzelevitch et al. 2007). Another carried the M54T
(rs74315447) in KCNE2, which was reported to alter the
transmembrane domain of MiRP1 that reduces potassium
currents leading to long QT syndrome and ventricular
fibrillation (Abbott et al. 1999; Splawski et al. 2000).
Five variants linked to cardiomyopathy were found in
our centenarian sample. The MYL2 A13T (rs104894363)
variant located in the regulatory light chain of myosin
was reported to be causal for a subtype of familial hypertrophic cardiomyopathy with onset of clinical symptoms
around middle age (Poetter et al. 1996; Andersen et al.
2001). The gene ABCC9 encodes the regulatory SUR2A
subunit of the cardiac ATP-sensitive potassium (KATP)
channel. Two centenarians carried the ABCC9 V734I variant (rs61688134), which was reported to increase the risk
of MI by 6.40-fold. (Minoretti et al. 2006). The G505S
(rs140740776) variant in JPH2 was reported to be associated with hypertrophic cardiomyopathy in a relatively
small sample of Japanese patients (Matsushita et al.
2007). One centenarian carried the TMEM43 R312W vari-
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ant linked to autosomal dominant arrhythmogenic right
ventricular cardiomyopathy/dysplasia (Haywood et al.
2013). Interestingly, one centenarian was found to be heterozygous for both JPH2 G505S and ABCC9 V734I and
another was heterozygous for both JPH2 G505S and
ANK2 E3931K.

Variants for other autosomal dominant and
X-chromosomal diseases
We found 18 rare ClinVar variants for other autosomal
dominant diseases (Table 4) and six mutations for Xchromosomal diseases (Table 5). These include variants
that increase the risk of metabolic disorders, including
hypercholesterolemia (LDLR, V827I, rs137853964), maturity-onset diabetes of the young (MODY) (BLK, A71T,
rs55758736), and obesity (MC4R, A175T, rs121913563).
One male and one female centenarian carried the
V1108M variant in TNXB (rs121912575) linked to the
dominant form of Ehlers–Danlos syndrome type 3
(Zweers et al. 2005). The remaining autosomal mutations
are annotated to cause a wide range of dominantly inherited phenotypes including metabolic, genitourinary, and
skin conditions as well as pediatric conditions, including
developmental syndromes, for example, the tetralogy of
Fallot, a severe malformation that would reduce life span.
Three centenarians presented a variant in TNFRSF1A
(R121Q, rs4149584) in the heterozygous state that was
linked to TNF-receptor associated periodic fever. This
was the only variant for dominantly inherited immune
disease in this dataset.
Aside from the above mentioned mutation in UBQLN2,
the observed X-chromosomal variants include three variants in the DMD gene that have been discussed as cause
of Duchenne and Becker muscular dystrophy. One frequent missense variant rs1800279 (H2921R) in the DMD
gene was observed in one male centenarian and another
male centenarian carried both rare variants rs1800278
(N2912D) and rs41305353 (E2910V). The carriers did not
have any documented muscle diseases.

Variants for recessive diseases and complex
diseases
Among the 72 variants for recessive traits, we found three
variants that were observed in the homozygous state in at
least one centenarian (Table S2). These are variants in
ADA, ALG6, and HPS5. The ALG6 variant Y131H
(rs35383149) has been annotated to cause congenital disorder of glycosylation, type Ic, a childhood onset metabolic disorder accompanied by severe neurological
symptoms (Miller et al. 2011). We found no literature
evidence supporting the pathogenicity of the ADA variant
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D8N (rs73598374) or the HPS5 variant T1098I
(rs61884288).
Three subjects were heterozygous carriers for Factor
V Leiden (F5, Q534R, rs6025) (Bertina et al. 1994).
Heterozygous carriers have elevated risks of deep venous
thrombosis, pulmonary embolism (Juul et al. 2004), and
stroke (Casas et al. 2004). Note that the GRCh37 genome
assembly presents the risk allele as the reference allele and
no individuals homozygous for the reference allele were
seen in our sample. One carrier had a history of MI and
another had a history of both MI and stroke, but the
third carrier had no known thrombotic diseases by the
age of 106 years.
Finally, we also identified homozygous individuals for
putative recessive disease alleles with relevance for longevity regardless of their population allele frequency. Of note,
we found three missense variants in the ACADS gene
R107C (rs61732144), R171W (rs1800556), and G209S
(rs1799958) (Tables S1 and S2) that were initially
reported (Corydon et al. 2001; Pedersen et al. 2008) in 10
patients with ethylmalonic aciduria and short-chain acylCoA dehydrogenase (SCAD) deficiency, a mitochondrial
fatty acid oxidation disorder causing neuromuscular phenotypes with hypotonia and developmental delay as the
prominent features of the disease. Homozygosity for
R107C as well as compound heterozygosity for R107C
and G209S have been described as disease causing in AJ
patients with SCAD with reduced penetrance (Tein et al.
2008) depending on other genetic modifiers or environmental stressors. Variants R171W and G209S have both
high allele frequencies (5.5% and 23.5%, respectively) in
the general population (U.S. and the Netherlands) and
they are considered to confer susceptibility for clinical
disease (van Maldegem et al. 2006). We found five AJ
centenarians who are homozygous for the variant G209S
(MAF = 36.4%) and they do not carry any other missense
variants in the ACADS gene. The carrier frequency for the
R107C variant in our centenarians (3/44) is identical to
the reported carrier frequency in AJ population (Tein
et al. 2008).

Discussion
In this study we observed many previously reported Mendelian mutations that are sufficiently benign to allow the
individual carriers to achieve exceptional longevity. The
presence of these specific variants in the genomes of centenarians can be helpful for clinical geneticists who are
challenged with the evaluation of their putative pathogenicity as incidental findings. More generally, our findings
support the notion that for many putative disease variants
it is not straightforward to decide whether they should be
regarded and acted upon as incidental findings, when they
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are observed in healthy individuals (Kingsmore 2013).
Several genes harboring putatively pathogenic variants in
our centenarians are on the list of 57 genes with reportable findings according to the ACMG recommendations
(Green et al. 2013b). These genes comprise 4 of the 24
genes for cancer (BRCA1, APC, RET, STK11), 1 of the 20
cardiac disease genes (TMEM43), 1 of the remaining 13
genes (LDLR). This demonstrates the challenge to identify
actionable mutations even in well-established disease
genes. The variants found in four of the cancer genes
APC, BRCA1, RET, and SDHB in our AJ centenarian
sample had also been labeled as “almost certainly benign”
in another sequencing study (ClinSeq) of 572 middle aged
participants (17% of which are of AJ ancestry) (Johnston
et al. 2012). Surprisingly, we also observed many rare
variants linked to dominantly inherited forms of diseases
that would clearly affect life expectancy. These disease
traits include cardiac diseases such as cardiomyopathy
and arrhythmia that increase the risk of sudden cardiac
death as well as metabolic diseases such as diabetes,
hypercholesterolemia, and obesity. One explanation for
the presence of disease alleles in centenarians might be
that these variants have incomplete penetrance as a result
of complex interplay between modifying genetic and environmental factors (Bergman et al. 2007; Cooper et al.
2013). However, for some variants the published evidence
may be viewed as too weak to uphold their classification
as pathogenic. For example, the three missense variants in
the DMD gene were all found in at least one male centenarian. Given the markedly reduced life expectancy of
patients affected by Duchenne muscular dystrophy (Kieny
et al. 2013), it is unlikely that these variants are pathogenic. In other cases, the resulting phenotypes of mutations could have little impact on longevity, which may
primarily apply to diseases such as deafness, glaucoma,
retinitis pigmentosa, premature ovarian failure, or ichthyosis. In other instances the possible influence on life
expectancy is not clear, such as the variant V1108M in
the TNXB gene, which was reported to cause Ehlers–
Danlos syndrome type 3 (Zweers et al. 2005) and shown
to affect the protein function (Zhuang et al. 2010).
We note that many presumable disease mutations are
present in centenarians with fairly high frequency. We did
not discuss these variants in detail because they are common in the ESP data. With the exception of the APOE e4
allele, these common variants are from the beginning
more likely to constitute polymorphisms than any clinically significant mutations. Despite its high population
frequency, the APOE e4 allele was suggested to follow
semi-dominant inheritance (Genin et al. 2011). APOE is
also the only reported gene reaching GWAS significance
threshold for longevity (Beekman et al. 2013). In our centenarian sample, the APOE e4 allele frequency is very
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similar to the previously reported allele frequencies in 325
French Caucasian centenarians (Schachter et al. 1994),
namely 5.2% for APOE e4 and 12.8% for APOE e2. In
the ESP dataset, the respective allele frequencies for e4
and e2 are 11.7% and 5.6% in European Americans and
18.9% and 8.7% in African Americans. This is congruent
with the previous finding that e4 was associated with
reduced and e2 with increased life span (Deelen et al.
2011). However, earlier studies did not observe any
homozygote centenarians for APOE e4. As would be
expected, the nonaffected APOE e4 homozygote had rare
coding variants in APOE modifier candidate genes, but
testing their significance needs to be left to subsequent
studies. The future identification of such protective
genetic factors in centenarians may increase the clinical
utility of the APOE e4 allele. Due to the relatively small
sample size and lack of a control data set from a matched
population, we cannot search for novel variants with
impact on longevity here.
In future, personalized genomic sequencing is likely to
generate many incidental findings. Rigorous investigations
for cosegregation in family members, large ancestrymatched population screening, and functional studies will
be required to identify those variants that are sufficiently
penetrant to be considered clinically relevant. Genetic
counseling provided by trained clinicians will be necessary
to communicate the potential impact of genetic variants
to avoid unnecessary and far reaching burden. This is
especially true in considering genetic screening in the
young, where the demarcation of putatively actionable
mutations needs to be approached with considerable caution, allowing appropriate balance to be conveyed in risk/
benefit discussions with parents. Our study provides a list
of variants that are currently flagged as pathogenic, but
are compatible with exceptional longevity. Thereby, our
study contributes to the genetic community’s efforts to
refine the set of variants with strong clinical significance
and mark previously reported disease mutations with
unclear clinical significance.
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